慢性HBV感染者血清IL-15和IL-16水平与HBV DNA载量的关系及临床意义探讨*

doi:10.3969/j.issn.1672-5069.2015.06.024

Abstract

Li Caidong， Chen Xilian Li Huijun et al.. Serum IL-15 and IL-16 levels in patients with hepatitis B and hepatitis B-related liver cirrhosis and liver cancer[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2015, 18(6): 663-664.

References

[1] 林曲,黄明声,温晶芸,等. 巨噬细胞移动抑制因子在原发性肝癌中的临床意义. 中山大学学报（医学科学版）,2007,28（3）：201-204.
[2] 余昶,熊永炎. 肝细胞性肝癌中MIF、CD147、MMP-9蛋白的表达及意义. 武汉大学学报（医学版）,2009,30（3）：358-361.
[3] Grabstein KH,Eisenman J,Shanebeck K,et a1. Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor. Science,1994,264（5161）:965-968.
[4] 杨春艳,苏先狮,李曼妮,等. 白细胞介素-15重组体对HBsAg核酸疫苗的免疫佐剂作用. 中华肝脏病杂志,2004,12（12）：758-759.
[5] 陈捷,王兰兰,付阳,等. IL-17、IL-23、TGF-β和IL-10在乙型肝炎病毒感染中的表达分析. 免疫学杂志,2012,28:231-236.
[6] 中华医学会肝病学分会和感染病学分会.慢性乙型肝炎防治指南（2010年版）. 实用肝脏病杂志,2011,14（2）：81-89.
[7] 赵永晓,冯丽英,刘艳瑾. 慢性 HBV 感染不同阶段肝脏局部细胞免疫状态与病毒复制的关系. 胃肠病学和肝病学杂志,2010,19（10）：889-892.
[8] 邹同. 不同HBV DNA载量慢性乙型肝炎患者血清MIF和IL-17的表达意义. 中国实用医药,2013,8（9）：7-8.
[9] Rothe H,Hibino T,Itoh Y,et al. Expression and rule of IL-16 mRNA in liver after infection with HBV in rats. Science,2000,10（3）: 251.
[10] 何登明,毛青,王宇明. 乙型肝炎病毒感染者血清Th1/Th2 型细胞因子水平及意义. 免疫学杂志,2004,20（5）：408-409.
[11] 唐先梅. 慢性乙型肝炎患者血清中IL-15、IL-16水平检测及意义. 石河子大学学报,2007,16（1）：21-23.
[12] 杨仲国,陈岳明,方美玉,等. 慢性乙型肝炎患者血清病毒载量与IFN-γ、IL-15含量关系探讨. 中国医师杂志,2002,4（8）：835-8361.

[1]	Zhuang Ying, Lin Zhihui.. Clinical manifestations and diagnosis of portal vein thrombosis [J]. Journal of Practical Hepatology, 2019, 22(6): 765-767.
[2]	chronic hepatitis B Zhu Lingyun, Zhang Maohai Cui Shasha, et al.. Serum IL-12 and IL-18 levels as well as peripheral blood mononuclear cell FOXp3 in patients with [J]. Journal of Practical Hepatology, 2019, 22(6): 816-819.
[3]	Shi Yingying, Wang Yuanxi.. Impact of combination telbivudine and adefovir dipivoxil on renal functions in the treatment of patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(6): 820-823.
[4]	Min Feng, Huang Wenqi, Wu Weibing, et al.. Implications of serum adipocytokine levels in patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(6): 824-827.
[5]	patients with chronic hepatitis B Zhang Yingming, Shen Shuang, Tian Fei, et al.. Prediction of response to peginterferon alfa-2a by blood IFNL4 and IL-28B gene polymorphisms in [J]. Journal of Practical Hepatology, 2019, 22(6): 828-831.
[6]	chronic hepatitis B virus carriers Wu Haiyi, Chen Jianxin.. Diagnostic efficacy of four non-invasive diagnostic models in evaluating significant liver fibrosis in [J]. Journal of Practical Hepatology, 2019, 22(6): 832-835.
[7]	Ma Liying, Shen Lijuan.. Efficacy and safety of tenofovir in the treatment of pregnant women with high HBV DNA loads [J]. Journal of Practical Hepatology, 2019, 22(6): 836-839.
[8]	Yang Caiyong, Chen Na, Li Kui, et al.. Clinical significance of peripheral blood Treg and Th17 cells in patients with chronic hepatitis C and hepatitis C-induced liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(6): 868-871.
[9]	Wu Dan Ma Xiangying.. Insulin resistance,carotid atherosclerosis and left ventricular function in patients with NAFLD-induced liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(6): 876-879.
[10]	He Zhi’an, Yu Liping, Lai Jiangqiong, et al.. Evaluation of varices bleeding and portal vein thrombosis by ARFI in patients with cirrhosis and esophagogastric varices [J]. Journal of Practical Hepatology, 2019, 22(6): 888-891.
[11]	Li Chuanjie, Xu Jing, Wang Liangliang, et al.. Changes of serum HBsAg levels in patients with chronic hepatitis B receiving entecavir treatment [J]. Journal of Practical Hepatology, 2019, 22(6): 928-929.
[12]	Du Keye, Yang Dongliang, Liu Jia. Regulatory T cells in hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(5): 613-616.
[13]	Liao Guichan, Peng Jie, Zhang Xiaoyong. Roles of hepatocytes in intrinsic innate immunity in control of hepatits B virus infection [J]. Journal of Practical Hepatology, 2019, 22(5): 617-619.
[14]	Zhao Xieshan, Wu Chunrong, Wang Chunfeng, et al. Preliminary study on the efficacy of combination of tenofovir and Anluo Huaxian pill in the treatment of patients with HBeAg-negative chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(5): 644-647.
[15]	Tu Jiexia, Wang An’na, Liao Ruoxi. Comparative study of interferon alpha -2b and peginterferon alpha -2a in the treatment of patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(5): 648-651.

Serum IL-15 and IL-16 levels in patients with hepatitis B and hepatitis B-related liver cirrhosis and liver cancer

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments